| Trial Identifier: | D9480C00023 |
| Sponsor: | AstraZeneca |
| Start Date: | March 2022 |
| Primary Completion Date: | December 2024 |
| Study Completion Date: | December 2024 |
| Condition: | Chronic Kidney Diseases |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version |
| Country | Location |
|---|---|
| BE | Bonheiden, BE, 2820 |
| BE | Leuven, BE, 3000 |
| ES | Algeciras, ES, 11207 |
| ES | Almería, ES, 04009 |
| ES | Badajoz, ES, 06080 |
| ES | Barcelona, ES, 08907 |
| ES | Burgos, ES, 9006 |
| ES | Getafe, ES, 28905 |
| ES | Madrid, ES, 28007 |
| ES | Madrid, ES, 28040 |
| ES | Salamanca, ES, 37007 |
| ES | San Sebastián de los Reyes, ES, 28702 |
| ES | Sevilla, ES, 41009 |
| ES | Talavera de la Reina, ES, 45600 |
| ES | Zamora, ES, 49022 |
| FR | ANNONAY, FR, 07103 |
| FR | Ars-Laquenexy, FR, 57530 |
| FR | Nice, FR, 06000 |
| FR | SAINT-PRIEST EN JAREZ, FR, 42270 |
| GB | Doncaster, GB, DN2 5LT |
| GB | Hull, GB, HU10 7AZ |
| GB | Salford, GB, M6 8HD |
| GB | Stevenage, GB, SG1 4AB |
| IT | Bari, IT, 70120 |
| IT | Foggia, IT, 71122 |
| IT | Parma, IT, 43125 |
| IT | Pavia, IT, 27100 |
| NL | Eindhoven, NL, 5602 ZA |